An update on multiple breath washout in children with cystic fibrosis

Area of Science:

• Pulmonary Medicine
• Genetics
• Medical Diagnostics

Background:

• Cystic fibrosis (CF) is a genetic disorder caused by CFTR gene mutations, leading to progressive lung disease.
• Early detection of lung function decline is critical for managing CF morbidity and mortality.
• The Lung Clearance Index (LCI) from multiple breath washout (MBW) is a sensitive indicator of early airway disease.

Purpose of the Study:

• To review the technical aspects and clinical relevance of LCI in cystic fibrosis.
• To compare LCI's advantages over traditional lung function tests.
• To explore LCI's application in CF clinical trials and routine care.

Main Methods:

• Focused literature review on LCI's utility in CF.
• Analysis of LCI's sensitivity compared to spirometry.
• Examination of LCI's role in evaluating treatment efficacy.

Main Results:

• LCI is more sensitive than spirometry for detecting early lung function decline in CF.
• LCI is increasingly used in pediatric and adult CF populations and recognized as an outcome measure in clinical trials.
• LCI implementation in routine care is established in Europe but less so in North America.

Conclusions:

• LCI is a valuable tool for early detection and monitoring of lung disease in CF.
• Advancements in testing protocols and interpretation tools will facilitate LCI's integration into routine CF care.
• LCI holds significant potential for improving CF patient management and treatment evaluation.